U.S. markets close in 5 hours 58 minutes
  • S&P 500

    3,621.07
    -14.34 (-0.39%)
     
  • Dow 30

    29,861.22
    -185.02 (-0.62%)
     
  • Nasdaq

    12,046.30
    +9.51 (+0.08%)
     
  • Russell 2000

    1,841.37
    -12.16 (-0.66%)
     
  • Crude Oil

    45.34
    +0.43 (+0.96%)
     
  • Gold

    1,814.10
    +9.50 (+0.53%)
     
  • Silver

    23.48
    +0.18 (+0.75%)
     
  • EUR/USD

    1.1909
    +0.0013 (+0.11%)
     
  • 10-Yr Bond

    0.8670
    -0.0150 (-1.70%)
     
  • GBP/USD

    1.3358
    -0.0000 (-0.00%)
     
  • USD/JPY

    104.3300
    -0.1500 (-0.14%)
     
  • BTC-USD

    19,238.01
    -28.64 (-0.15%)
     
  • CMC Crypto 200

    381.37
    +10.86 (+2.93%)
     
  • FTSE 100

    6,399.40
    -32.77 (-0.51%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Radius Health to Present at Jefferies 2019 Global Healthcare Conference in London

WALTHAM, Mass., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (RDUS), today announced that Jesper Hoeiland, President and CEO of the Company, will present a corporate update at the Jefferies 2019 Global Healthcare Conference in London, United Kingdom on Wednesday, November 20, 2019 at 6:00 p.m. GMT.

Information on the presentation is as follows:

Event:

Jefferies Global Healthcare Conference in London

Date:

Wednesday, November 20, 2019

Time:

6:00 p.m. GMT

A live webcast of the presentation will be available by visiting the Investors section of the Company’s website at https://ir.radiuspharm.com/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About Radius

Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics. For more information, please visit www.radiuspharm.com.

Investor Relations Contact:

Elhan Webb, CFA
Email: ewebb@radiuspharm.com
Phone: 617-551-4011